Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Survey of Patients Taking IOP-Lowering Eye Drops
A Multi-Site Questionnaire-Based Study to Assess Attitudes Regarding Current IOP-Lowering Eye Drops and Products in Development for Sustained Release of Medication in Glaucomatous and Ocular Hypertensive Subjects
Status: Enrolling
Updated:  3/4/2015
ForSight VISION5 Recruitment Referral Center
mi
from
Menlo Park, CA
Survey of Patients Taking IOP-Lowering Eye Drops
A Multi-Site Questionnaire-Based Study to Assess Attitudes Regarding Current IOP-Lowering Eye Drops and Products in Development for Sustained Release of Medication in Glaucomatous and Ocular Hypertensive Subjects
Status: Enrolling
Updated: 3/4/2015
ForSight VISION5 Recruitment Referral Center
mi
from
Menlo Park, CA
Click here to add this to my saved trials
DHA and X-Linked Retinitis Pigmentosa
Investigation of Effectiveness and Safety of High Dose Docosahexaenoic Acid (DHA) in X-Linked Retinitis Pigmentosa
Status: Enrolling
Updated:  3/4/2015
Retina Foundation of the Southwest
mi
from
Dallas, TX
DHA and X-Linked Retinitis Pigmentosa
Investigation of Effectiveness and Safety of High Dose Docosahexaenoic Acid (DHA) in X-Linked Retinitis Pigmentosa
Status: Enrolling
Updated: 3/4/2015
Retina Foundation of the Southwest
mi
from
Dallas, TX
Click here to add this to my saved trials
Clinical Evaluation of MyDay™ and 1-DAY ACUVUE® TruEye®
Clinical Evaluation of MyDay™ Daily Disposable Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated:  3/18/2015
Alcon Call Center
mi
from
Fort Worth, TX
Clinical Evaluation of MyDay™ and 1-DAY ACUVUE® TruEye®
Clinical Evaluation of MyDay™ Daily Disposable Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 3/18/2015
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis
A Prospective, Double-masked, Placebo Controlled Comparison of Topical 0.15% Ganciclovir Gel (Zirgan®) Versus 0.3% Hypromellose Gel (Genteal Gel®; Placebo) for the Treatment of Adenovirus Conjunctivitis
Status: Enrolling
Updated:  3/30/2015
Lifelong Vision Foundation
mi
from
Chesterfield, MO
A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis
A Prospective, Double-masked, Placebo Controlled Comparison of Topical 0.15% Ganciclovir Gel (Zirgan®) Versus 0.3% Hypromellose Gel (Genteal Gel®; Placebo) for the Treatment of Adenovirus Conjunctivitis
Status: Enrolling
Updated: 3/30/2015
Lifelong Vision Foundation
mi
from
Chesterfield, MO
Click here to add this to my saved trials
OCT-guided LALAK in Children
Randomized Clinical Trial of OCT-guided Laser-assisted Lamellar Anterior Keratoplasty in Children
Status: Enrolling
Updated:  4/21/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
OCT-guided LALAK in Children
Randomized Clinical Trial of OCT-guided Laser-assisted Lamellar Anterior Keratoplasty in Children
Status: Enrolling
Updated: 4/21/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Stimulus Parameters in Flicker Electroretinogram (ERG)
Study of Stimulus Parameters in Flicker Electroretinogram (ERG)
Status: Enrolling
Updated:  6/8/2015
Wedgwood Optometry
mi
from
Fort Worth, TX
Study of Stimulus Parameters in Flicker Electroretinogram (ERG)
Study of Stimulus Parameters in Flicker Electroretinogram (ERG)
Status: Enrolling
Updated: 6/8/2015
Wedgwood Optometry
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Paediatric Safety Study in Cat-PAD
A Multi-Centre, Single-Blind Study to Assess the Safety of Cat-PAD in Cat Allergic Paediatric Subjects
Status: Enrolling
Updated:  6/11/2015
Peninsula Research Associates Inc
mi
from
Rolling Hills Estate, CA
Paediatric Safety Study in Cat-PAD
A Multi-Centre, Single-Blind Study to Assess the Safety of Cat-PAD in Cat Allergic Paediatric Subjects
Status: Enrolling
Updated: 6/11/2015
Peninsula Research Associates Inc
mi
from
Rolling Hills Estate, CA
Click here to add this to my saved trials
Paediatric Safety Study in Cat-PAD
A Multi-Centre, Single-Blind Study to Assess the Safety of Cat-PAD in Cat Allergic Paediatric Subjects
Status: Enrolling
Updated:  6/11/2015
Allergy Associates Research Center
mi
from
Portland, OR
Paediatric Safety Study in Cat-PAD
A Multi-Centre, Single-Blind Study to Assess the Safety of Cat-PAD in Cat Allergic Paediatric Subjects
Status: Enrolling
Updated: 6/11/2015
Allergy Associates Research Center
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration
A Phase I Study of the Inhibition of LFA-1 to Intercellular Adhesion Molecule-1 (ICAM-1) Using Subcutaneous Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration (SEIRA)
Status: Enrolling
Updated:  7/6/2015
Vitreous-Retina-Macula Consultants of New York
mi
from
New York, NY
Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration
A Phase I Study of the Inhibition of LFA-1 to Intercellular Adhesion Molecule-1 (ICAM-1) Using Subcutaneous Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration (SEIRA)
Status: Enrolling
Updated: 7/6/2015
Vitreous-Retina-Macula Consultants of New York
mi
from
New York, NY
Click here to add this to my saved trials
Sirolimus Injections for Autoimmune Scleritis
A Phase I/II Study to Investigate Subconjunctival Sirolimus for the Treatment of Active Autoimmune Non-Necrotizing Anterior Scleritis
Status: Enrolling
Updated:  7/7/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Sirolimus Injections for Autoimmune Scleritis
A Phase I/II Study to Investigate Subconjunctival Sirolimus for the Treatment of Active Autoimmune Non-Necrotizing Anterior Scleritis
Status: Enrolling
Updated: 7/7/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells
A Randomized Prospective Double Masked Controlled Trial Comparing Ketorolac Tromethamine 0.4% and Prednisolone Acetate 1% in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells.
Status: Enrolling
Updated:  7/8/2015
University of Colorado Eye Center
mi
from
Aurora, CO
Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells
A Randomized Prospective Double Masked Controlled Trial Comparing Ketorolac Tromethamine 0.4% and Prednisolone Acetate 1% in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells.
Status: Enrolling
Updated: 7/8/2015
University of Colorado Eye Center
mi
from
Aurora, CO
Click here to add this to my saved trials
The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface
The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface
Status: Enrolling
Updated:  7/8/2015
University of Colorado Eye Center
mi
from
Aurora, CO
The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface
The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface
Status: Enrolling
Updated: 7/8/2015
University of Colorado Eye Center
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of Abicipar Pegol in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Gilbert, AZ
A Study of Abicipar Pegol in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Gilbert, AZ
Click here to add this to my saved trials
A Study of Abicipar Pegol in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Abilene, TX
A Study of Abicipar Pegol in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Abilene, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Beverly Hills, CA
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Miami, FL
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Tamarac, FL
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Tamarac, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Tampa, FL
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Atlanta, GA
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Chicago, IL
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Chicago, IL
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Ellsworth, ME
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Ellsworth, ME
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Baltimore, MD
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Baltimore, MD
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Detroit, MI
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Palisades Park, NJ
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Palisades Park, NJ
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Belmont, NC
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Belmont, NC
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Durham, NC
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Portland, OR
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Dallas, TX
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Houston, TX
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Houston, TX
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
McAllen, TX
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
McAllen, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
San Antonio, TX
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Temple, TX
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Temple, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Norfolk, VA
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
mi
from
Morgantown, WV
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
mi
from
Buenos Aires,
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
mi
from
Buenos Aires,
Click here to add this to my saved trials
Global DuoTrav® Study
Prospective, Randomized, Multi-Center Study to Evaluate the Efficacy and Tolerability of DuoTrav® in Patients Previously Uncontrolled on a Beta-blocker
Status: Enrolling
Updated:  7/13/2015
Contact Alcon Call Center for Trial Locations
mi
from
Fort Worth, TX
Global DuoTrav® Study
Prospective, Randomized, Multi-Center Study to Evaluate the Efficacy and Tolerability of DuoTrav® in Patients Previously Uncontrolled on a Beta-blocker
Status: Enrolling
Updated: 7/13/2015
Contact Alcon Call Center for Trial Locations
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride
A Phase 2b/3 Multicenter, Randomized, Double-Masked, Dose-Ranging Study Comparing the Efficacy and Safety of Emixustat Hydrochloride (ACU-4429) With Placebo for the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride
A Phase 2b/3 Multicenter, Randomized, Double-Masked, Dose-Ranging Study Comparing the Efficacy and Safety of Emixustat Hydrochloride (ACU-4429) With Placebo for the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
DAILIES® AquaComfort Plus® MF - Comparative Assessment of Visual Performance-PART 2
Comparative Assessment of Visual Performance Between DAILIES® AquaComfort Plus® MF and PROCLEAR 1 Day MF
Status: Enrolling
Updated:  7/21/2015
Contact Alcon Call Center for Trial Locations
mi
from
Fort Worth, TX
DAILIES® AquaComfort Plus® MF - Comparative Assessment of Visual Performance-PART 2
Comparative Assessment of Visual Performance Between DAILIES® AquaComfort Plus® MF and PROCLEAR 1 Day MF
Status: Enrolling
Updated: 7/21/2015
Contact Alcon Call Center for Trial Locations
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
Status: Enrolling
Updated:  7/22/2015
Clinical Research Facility
mi
from
Newport Beach, CA
Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 7/22/2015
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials